1158. Immunogenicity of COVID-19 vaccine four-dose series in healthy community dwelling adults 50 years and above: interim analysis from the ‘PRospEctiVe EvaluatioN of immuniTy after COVID-19 vaccines’ (PREVENT-COVID) study

BACKGROUND: Adults aged > 50 years are at increased risk for severe coronavirus disease 2019 (COVID-19). This study evaluated immunogenicity of COVID-19 vaccines in healthy adults aged > 50 years through quantification of antigen specific antibody concentration and function post-vaccination wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaultier, Gabrielle N, McMillan, Brynn, Lo, Mandy, Cai, Bing, Zheng, Jean, Shulha, Hennady, Simmons, Karen, Marquez, Ana Citlali, Bartlett, Sofia R, Sekirov, Inna, Zlosnik, James, Morshed, Muhammad, Skowronski, Danuta, Jassem, Agatha N, Sadarangani, Manish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676842/
http://dx.doi.org/10.1093/ofid/ofad500.998

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676842/
http://dx.doi.org/10.1093/ofid/ofad500.998

Ejemplares similares